logo

Celldex Therapeutics Inc. (CLDX)



Trade CLDX now with
  Date
  Headline
5/6/2020 8:07:07 AM Celldex Says Results From Phase 1 Study Of CDX-0159 Accepted As Late-breaking Poster Presentation At EAACI
11/18/2019 8:16:55 AM Celldex Says Phase 1a Study Of CDX-0159 Has Initiated In Healthy Volunteers
6/24/2019 8:06:25 AM Celldex Therapeutics Appoints Diane Young SVP, Chief Medical Officer
2/8/2019 12:21:42 PM Celldex Therapeutics Announces 1 For 15 Reverse Stock Split
11/9/2018 8:02:47 AM Celldex Presents Promising Interim Data From Phase 1 Study Of Differentiated CD40 Agonist CDX-1140
11/7/2018 4:11:03 PM Celldex Therapeutics Q3 Loss/share $0.04 Vs. Loss $0.20 Year Ago
8/8/2018 4:03:58 PM Celldex Therapeutics Q2 Loss/share $0.11 Vs. Loss $0.23 Year Ago
5/10/2018 8:04:17 AM Celldex Therapeutics Q1 Loss Per Share $0.84 Vs Loss $0.28 Last Year
4/16/2018 7:01:36 AM Celldex Says METRIC Study In Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint